Amy Israel: Join BIO2025 session on groundbreaking strategies to make medicines available in resource-challenged markets
Amy Israel, Senior Advisor, Access to Medicines at Union for International Cancer Control (UICC), shared a post on LinkedIn:
“Attending BIO2025 next week in Boston? Trying to crack the nut on access to medicines in resource-challenged contexts? Do you believe access to innovation should be the norm? Join our session to figure it out together.
Session – Profit and access: Groundbreaking strategies to make medicines available in resource-challenged markets
When – 16 June 16:15-17:15
Where – BIO International Convention, room 208With esteemed panelists and access evangelists – Clifford Samuel | Aparna Parikh | Anand Reddi | Keith Flaherty
and stellar moderation by Jeffrey Sturchio.”
Aparna Parikh, GI oncologist at Massachusetts General Hospital and Associate Professor at the Harvard Medical School, shared a post on LinkedIn by Amy Israel, adding:
“We still have a long way to go to achieve equitable access to cancer care across the continuum.
At the heart of every cancer discussion, we must ask: How are we going to get this to the 70% + of the world where the disease burden is highest, but access is the most limited?
Over the years, I’ve been told that focusing on access in resource-constrained settings is a distraction. But I believe the opposite: if we center our work around the places with the fewest resources, we push ourselves toward solutions that lead to better cancer care for everyone.
Equity isn’t the side story—it’s the main narrative.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023